Hypofractionated palliative radiotherapy for bladder cancer
- 16 May 2015
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 24 (1) , 181-186
Abstract
The aim of this study was to evaluate hematuria-free survival as well as acute and late toxicity after hypofractionated palliative radiotherapy for bladder cancer.Keywords
This publication has 22 references indexed in Scilit:
- Evaluation of Acute Toxicity and Symptoms Palliation in a Hypofractionated Weekly Schedule of External Radiotherapy for Elderly Patients with Muscular Invasive Bladder CancerInternational braz j urol, 2013
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder CancerNew England Journal of Medicine, 2012
- Association Between Smoking and Risk of Bladder Cancer Among Men and WomenJAMA, 2011
- Bladder Cancer Mortality of Workers Exposed to Aromatic Amines: A 58-Year Follow-upJNCI: Journal of the National Cancer Institute, 2010
- The present and future burden of urinary bladder cancer in the worldWorld Journal of Urology, 2009
- Trimodality Treatment and Selective Organ Preservation for Bladder CancerJournal of Clinical Oncology, 2006
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancerUrology, 2002
- Hypofractionated radiotherapy for invasive bladder cancerRadiotherapy and Oncology, 1997
- Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderlyRadiotherapy and Oncology, 1997